Su et al. (130) also reported an unexpected finding that AIM2 is recruited to the phagosomes and activated following antibody-dependent cellular phagocytosis (ADCP), which subsequently caused immunosuppression in HER2+ breast cancer. This evidence concerns the gene ERBB2 and breast cancer.